Evercore ISI analyst David Raso upgraded ESAB (ESAB) to In Line from Underperform with a price target of $120, down from $122. Along with Q4 ...
ESAB Corp (ESAB) stock fell about 2.7% over the past week, but Evercore ISI upgraded the stock to ‘In Line’ from ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Hosted on MSN32m
Home Depot Earnings Due As HD, Lowe's Try To Put In A FloorHome Depot and Lowe's have a low bar to clear for their respective fiscal fourth-quarter earnings reports tomorrow and ...
Akamai Technologies (NASDAQ:AKAM – Free Report) had its target price cut by Susquehanna from $110.00 to $105.00 in a research ...
Akamai Technologies (NASDAQ:AKAM – Free Report) had its target price lowered by JPMorgan Chase & Co. from $76.00 to $72.00 in ...
Wall Street expects Nvidia to crush earnings again, with AI demand fueling a historic surge--will the stock skyrocket next?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback